WILLIAM ROSE

Insider Reports History

Location
Dallas, TX
Signature
/s/ Charles E. Gale, Attorney-In-Fact for William E. Rose
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by WILLIAM ROSE:

Company Role Class Num Shares Value Price $ Report Date Ownership
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 26 Sep 2023 By trust
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 26 Sep 2023 Direct
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 26 Sep 2023 Indirect
REATA PHARMACEUTICALS INC Director Class B Common Stock 0 $172.03 26 Sep 2023 Direct
REATA PHARMACEUTICALS INC Director Class B Common Stock 0 $172.03 26 Sep 2023 Indirect
REATA PHARMACEUTICALS INC Director Stock Option (right to buy) 0 26 Sep 2023 Direct

Insider Reports Filed by WILLIAM ROSE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924323019543-rose-william-2023-09-26 REATA PHARMACEUTICALS INC 26 Sep 2023 31 $0 4 Director 26 Sep 2023, 16:30
/report/000089924323019264-rose-william-2023-09-15 REATA PHARMACEUTICALS INC 15 Sep 2023 8 $0 4 Director 19 Sep 2023, 16:30
/report/000089924323018374-rose-william-2023-08-23 REATA PHARMACEUTICALS INC 23 Aug 2023 1 $0 4 Director 24 Aug 2023, 16:41
/report/000089924323015212-rose-william-2023-06-07 REATA PHARMACEUTICALS INC 07 Jun 2023 2 +$79,943 4 Director, Member of 10% owner group, 10%+ Owner 09 Jun 2023, 17:00
/report/000089924322021915-rose-william-2022-06-08 REATA PHARMACEUTICALS INC 08 Jun 2022 2 +$79,987 4 Director, Member of 10% owner group, 10%+ Owner 10 Jun 2022, 16:30
/report/000089924321023534-rose-william-2021-06-10 REATA PHARMACEUTICALS INC 10 Jun 2021 2 +$67,424 4 Director, Member of 10% owner group, 10%+ Owner 14 Jun 2021, 16:05